Human Augmentation Will Create the First Objectively Superior Humans — With Heritable Advantages
The Claim
For most of human history, the advantages that differentiated individuals — strength, intelligence, health, longevity — were matters of degree rather than kind. Augmentation technologies throughout the industrial era (glasses, pacemakers, cochlear implants) corrected deficits or restored function. The convergence Amy Webb described at SXSW is categorically different: not correction, but objective superiority. And if heritable gene edits become normalized, that superiority becomes transmissible across generations.
The Convergence Calculation
Webb's core demonstration was arithmetical. Three commercially available consumer products, combined:
- AI sleep bed: 30% more restful sleep (based on EEG data and adaptive temperature regulation)
- Leisure exoskeleton: 40% more physical activity per hour of effort
- AR smart glasses: 20% greater task efficiency through real-time information overlay
Stacked, these produce approximately 2.2x greater effective daily capacity than an unaugmented peer. Webb's framing was explicit: for the first time in history, some humans are objectively more capable than others — not more practiced, not more disciplined, not taller — but objectively more effective per unit of time and biological resource.
The honest caveat is methodological. Multiplying manufacturer specification claims produces an upper-bound estimate, not a real-world validated finding. The person who consistently maintains all three systems, optimizes their interaction, and experiences the manufacturer-claimed benefits simultaneously is an idealized user, not a population average.
The Heritable Dimension
The CRISPR finding is where the hypothesis becomes most consequential and most contested. Webb cited evidence that gene editing in embryos targeting the CCR5 gene — associated with HIV resistance and, critically, also linked to enhanced cognitive ability — is already occurring in research contexts. If this is accurate, it represents a qualitative shift from somatic augmentation (changing the individual) to germline augmentation (changing the lineage).
The 2018 He Jiankui case — in which a Chinese researcher modified embryo genes and produced live births, drawing international condemnation — established that the technical capability exists. What does not yet exist is the social, regulatory, and economic infrastructure for this to become a mainstream practice. Webb's scenario treats this as a near-future trajectory rather than a current reality.
The Stratification Concern
Webb's most provocative claim is that biological stratification — where human capabilities diverge based on access to augmentation rather than natural variation — is qualitatively different from prior inequality. Prior technological advantages were extrinsic (richer people have better tools, education, nutrition). Heritable genetic advantages are intrinsic: they are encoded in the body of the next generation, persisting independently of any maintained external technology or ongoing resource access.
Historical precedent complicates this scenario. Literacy, vaccines, electricity, and mobile phones all began as advantages for the privileged and diffused across the population over time. The democratization of capability is a well-documented historical pattern. What Webb is arguing is that heritable biological modifications — once made — cannot be un-made by social policy, distinguishing this from all prior technology diffusion scenarios.
The Confidence Problem
The SXSW presentation delivered this scenario without contradiction because no other speaker addressed augmentation convergence directly. The claim was presented as scenario planning — which is the honest framing for a futures analyst describing 10-15 year trajectories — rather than as contested empirical evidence about current reality. The partially supported verdict reflects the gap between the real and current technology evidence (augmentation devices exist, CRISPR research exists, BCIs exist) and the social and regulatory trajectory evidence (normalized heritable editing does not yet exist).